8-K 1 medamicus025866_8k.txt MEDAMICUS, INC. FORM 8K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 12, 2002 MedAmicus, Inc. --------------- (Exact name of Registrant as specified in its charter) Minnesota 0-19467 41-1533300 ---------------------------- ---------------------- ---------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 15301 Highway 55 West Plymouth, Minnesota 55447 ------------------------------ ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (763) 559-2613 Items 1, 2, 3, 4, 5, 6, and 8 are not applicable and therefore omitted. ITEM 9. REGULATION FD DISCLOSURE. --------------------------------- The President and Chief Executive Officer of MedAmicus, Inc. (the "Company"), James D. Hartman, intends to use the slide presentation attached hereto as Exhibit 99.1 which summarizes information about the Company, its products, industry and prospects. The information contained in the slides will be presented to securities fund managers and securities analysts in individual meetings. Also attached to this Form 8-K as Exhibit 99.2 is a description of risks relating to the Company's business. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS ------------------------------------------ 99.1 MedAmicus, Inc. Investor Presentation December 2002 99.2 MedAmicus, Inc. Risks Relating to Our Business dated December 12, 2002 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDAMICUS, INC. By: /s/ James D. Hartman ----------------------------------------- President and Chief Executive Officer Dated: December 12, 2002